Trial intelligence / Profile preview

Ultrasound Guided Stellate Ganglion Block for Cerebral Vasospasm

NCT02775318Phase 1Completed

Sponsor
Post Graduate Institute of Medical Education and Research
Start
Sep 2014
Primary completion
Apr 2015
Modality
Small Molecules
01

Overview

Phase 1, single-blind, single-arm trial of bupivacaine in cerebral vasospasm, sponsored by Post Graduate Institute of Medical Education and Research. Primary endpoints: Glasgow Coma Scale at 48 hours, Motor Power on Motor System Examination at 48 hours and 1 more. Started Sep 2014; status: completed.

02

Drugs

bupivacaine
03

Conditions

cerebral vasospasm

Beyond the preview

Go deeper on NCT02775318.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02775318.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call